Concordant Comorbidities in Diabetes: Prevalence, Determinants, and Distribution Patterns among Patients Attending the Ashanti Mampong Municipal Government Hospital.
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
OBIRI-YEBOAH, Daniel
Abstract
Nowadays diabetic comorbidities constitute a major public health problem in Ghanaian context. However, there is a dearth of evidence in epidemiology and determinants of diabetic comorbidity in Ghana, particularly in the study setting.
Therefore, this study was conducted to estimate the prevalence, examine the determinants associated and assess the socio-demographic predictors of concordant comorbidities among diabetes patients attending the Ashanti Mampong Government Hospital. A hospital-based cross-sectional study was conducted, with a total of 430 diabetic patients were selected using the simple random sampling without replacement (SRSWOR) technique.
Bivariable and multivariable logistic regression analysis were carried out using Stata version 19 (StateCorp LLC, College Station, TX, USA). Descriptive and inferential statistics were employed in the data in analysis. To measure the strength of association and Adjusted Odds Ratio (AOR) with 95% Confidence Interval (CI) was used. Moreover, variables with p-value ≤ 0.05 were considered as statistically significant with the outcome variable.
In this study, it is found that the overall prevalence of concordant comorbidity among adult diabetic out-patients was 84.0% (95% CI: 80.2 – 87.3).
Moreover, more than two-third of patients, 96.9% were diagnosed for type two diabetic mellitus (T2DM). Age ≥ 55 years (AOR = 7.61; 95% CI: 2.14 – 10.71; p = 0.034), female (AOR = 3.89; 95% CI: 1.92 – 5.10; p = 0.028), T2DM (AOR = 2.38, 95% CI: 1.57–3.59, p = 0.000), ≥5 years duration of treatments (AOR = 9.04, 95% CI: 2.02–12.88, p = 0.036), and poor glycaemic control (AOR = 1.31, 95% CI: 1.02–2.67, p = 0.000) were factors significantly associated with concordant diabetic comorbidity.
The findings underscore the importance of early detection and timely, appropriate management of diabetic comorbidities to improve patients’ quality of life and overall functional status.
